PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

BMC study: New Hepatitis C treatments cost-effective, but only for selected patients

2015-03-30
(Press-News.org) BOSTON -A study led by Boston Medical Center (BMC) researchers demonstrates that while new therapies to treat Hepatitis C Virus (HCV) are highly effective, they are cost-effective and provide the greatest value in specific groups of HCV-infected patients. The findings of the study, led by Benjamin P. Linas, MD, MPH, from BMC's section of infectious diseases and the Boston University School of Medicine (BUSM), are published in the Annals of Internal Medicine.

The study focused on the combination of sofosbuvir and ribavirin for treatment of HCV genotypes 2 and 3, which account for approximately one quarter of all HCV cases in the United States. These medications were the first all oral combination therapy approved for the treatment of HCV. While this medication regimen is effective in curing more than 90 percent of patients, the wholesale cost of sofosbuvir is approximately $85,000 per treatment course, which has strained insurance budgets and led to treatment restrictions.

Using a simulation model, Linas and colleagues projected outcomes, costs, and cost-effectiveness of sofosbuvir-based treatments for HCV genotype 2 or 3 infection in the US. They found that at these costs, sofosbuvir-based HCV therapy provides excellent economic value in genotype 2 or 3 infected patients who already have advanced liver disease. It also is cost-effective for patients who have already previously failed treatment with other drugs.

For patients without liver disease and who have never before been treated for HCV, however, these therapies cost well over $100,000 for each quality-adjusted life year gained, suggesting that for this healthier group of patients, the medication cost is too high to be considered cost-effective.

"These new oral treatments provide better clinical results with fewer side effects for all patients, but at the current price, are only good value for those who need treatment the most - patients with advanced liver disease or those who failed prior therapy," Linas said. "With lower costs, it would be reasonable to provide these better regimens to all patients."

INFORMATION:

This study was funded in part by the National Institute on Drug Abuse and the National Institute of Allergy and Infectious Disease under notice of grant award numbers R01DA031059, R01DA027379, and R37AI042006 and was carried out in collaboration with researchers at the University of Chicago, Weill Cornell Medical College, the Harvard School of Public Health, and Massachusetts General Hospital.

About Boston Medical Center

Boston Medical Center is a private, not-for-profit, 482-bed, academic medical center that is the primary teaching affiliate of Boston University School of Medicine. It is the largest and busiest provider of trauma and emergency services in New England. Committed to providing high-quality health care to all, the hospital offers a full spectrum of pediatric and adult care services including primary and family medicine and advanced specialty care with an emphasis on community-based care. Boston Medical Center offers specialized care for complex health problems and is a leading research institution, receiving more than $118 million in sponsored research funding in fiscal year 2014. It is the 11th largest recipient of funding in the U.S. from the National Institutes of Health. In 1997, BMC founded Boston Medical Center Health Plan, Inc., now one of the top ranked Medicaid MCOs in the country, as a non-profit managed care organization. It does business in Massachusetts as BMC HealthNet Plan and as Well Sense Health Plan in New Hampshire, serving more than 315,000 people, collectively. Boston Medical Center and Boston University School of Medicine are partners in the Boston HealthNet - 14 community health centers focused on providing exceptional health care to residents of Boston. For more information, please visit http://www.bmc.org.



ELSE PRESS RELEASES FROM THIS DATE:

Study shows short & long-term cost-savings associated with minimally invasive surgery

2015-03-30
CLEVELAND - Adding to the clinical benefits and improved patient outcomes associated with minimally invasive surgery, Medtronic highlighted a study published in the March 25 online edition of JAMA Surgery. The new study demonstrated that patients who underwent laparoscopic colectomy procedures required fewer days of health care utilization and the health care system spent less on their acute and follow-up care than those who underwent traditional open surgery. "We found that the use of minimally invasive laparoscopic approaches in a select group of patients undergoing ...

New data show that women of childbearing age need more vegetables, white potatoes

2015-03-30
(Boston, MA) March 30, 2015 - A new study presented today at Experimental Biology 2015 confirms that vegetable consumption is very low among women of childbearing age (WCBA), and that the nutrient-rich white potato is an important vegetable to this population's diet, particularly among subgroups with the lowest intake. The results are consistent with the Institute of Medicine findings that mean total vegetable consumption of women ages 19 to 50 years is extremely low--with intakes at just 50% of the 2.5 cup equivalents per day recommended for most WCBA by the 2010 Dietary ...

Mist-collecting plants may bioinspire technology to help alleviate global water shortages

Mist-collecting plants may bioinspire technology to help alleviate global water shortages
2015-03-30
WASHINGTON D.C., March 30, 2015 - Plants living in arid, mountainous and humid regions of the planet often rely on their leaves to obtain the moisture they need for survival by pulling mist out of the air. But how exactly they manage this feat has been a bit of a mystery--until now. By studying the morphology and physiology of plants with tiny conical "hairs" or microfibers on the surface of their leaves, such as tomatoes, balsam pears and the flowers Berkheya purpea and Lychnis sieboldii, a team of researchers in Japan uncovered water collection-and-release secrets that ...

To statin or not to statin?

2015-03-30
Cholesterol-lowering statins have transformed the treatment of heart disease. But while the decision to use the drugs in patients with a history of heart attacks and strokes is mostly clear-cut, that choice can be a far trickier proposition for the tens of millions of Americans with high cholesterol but no overt disease. Now a report from preventive cardiologists at Johns Hopkins and elsewhere offers a set of useful tips for physicians to help their patients make the right call. The report, published March 30 in the Journal of the American College of Cardiology, combines ...

York U study: Functional decline in women at Alzheimer's risk relates to deteriorating brain wiring

2015-03-30
TORONTO, March 30, 2015 - In their latest brain imaging study on women at risk for Alzheimer's disease, York University researchers have found deterioration in the pathways that serve to communicate signals between different brain regions needed for performing everyday activities such as driving a car or using a computer. "We observed a relationship between the levels of deterioration in the brain wiring and their performance on our task that required simultaneous thinking and moving; what we see here is a result of communication failure," explains Professor Lauren Sergio ...

Oral drug normalizes blood potassium in 98 percent of kidney patients

2015-03-30
SAN ANTONIO, Texas, U.S.A. (March 30, 2015) -- Patients with chronic kidney disease may be treated with a class of medications called Renin Angiotensin Aldosterone System inhibitors (RAASI's). Although these drugs protect the heart and kidney, a significant percentage of patients develop a dangerous side effect -- high potassium levels in the blood (hyperkalemia). Elevated potassium puts patients at risk of death from cardiac arrhythmias. Lacking a drug to treat the problem, doctors either stop these beneficial drugs or may use kidney dialysis to quickly lower the potassium. At ...

Teens with breast lumps may be able to avoid invasive biopsy

2015-03-30
If a lump is found in the breast of an adolescent girl, she often will undergo an excisional biopsy. However, breast cancer is rare in adolescents, and the vast majority of teenage breast lumps turn out to be benign masses that are related to hormones and often go away over time. A recent Loyola University Health System study published in the Journal of Ultrasound in Medicine suggests that a breast ultrasound examination might eliminate the need for biopsy in many cases. Loyola radiologists studied 37 teen girls with a total of 45 breast lumps to determine whether ...

How DNA alarm-system works

How DNA alarm-system works
2015-03-30
The DNA molecule is chemically unstable giving rise to DNA lesions of different nature. That is why DNA damage detection, signaling and repair, collectively known as the DNA damage response, are needed. The DNA damage response is immensely important, for example, for ensuring the highest possible quality of the DNA before replication - duplication of the DNA prior to cell division. If the damaged DNA is replicated, the risk of cancer and other diseases increases significantly due to mutations. All in all this may lead to the death of a cell itself. DNA repair consists ...

Fasting and less-toxic cancer drug may work as well as chemotherapy

2015-03-30
Fasting in combination with chemotherapy has already been shown to kill cancer cells, but a pair of new studies in mice suggests that a less-toxic class of drugs combined with fasting may kill breast, colorectal and lung cancer cells equally well. If shown to work in humans, this combination could replace chemotherapy and make fasting a potent component of a long-term strategy to treat cancer, according to senior author Valter Longo of USC. Human clinical trials in the United States and Europe are already studying the effectiveness and safety of Longo's strategy of ...

Study: Functional decline in woman at risk for Alzheimer's relates to deteriorating brain

2015-03-30
TORONTO, March 30, 2015 - In their latest brain imaging study on women at risk for Alzheimer's disease, York University researchers have found deterioration in the pathways that serve to communicate signals between different brain regions needed for performing everyday activities such as driving a car or using a computer. "We observed a relationship between the levels of deterioration in the brain wiring and their performance on our task that required simultaneous thinking and moving; what we see here is a result of communication failure," explains Professor Lauren Sergio ...

LAST 30 PRESS RELEASES:

Spring fatigue cannot be empirically proven

Do prostate cancer drugs interact with certain anticoagulants to increase bleeding and clotting risks?

Many patients want to talk about their faith. Neurologists often don't know how.

AI disclosure labels may do more harm than good

The ultra-high-energy neutrino may have begun its journey in blazars

Doubling of new prescriptions for ADHD medications among adults since start of COVID-19 pandemic

“Peculiar” ancient ancestor of the crocodile started life on four legs in adolescence before it began walking on two

AI can predict risk of serious heart disease from mammograms

New ultra-low-cost technique could slash the price of soft robotics

Increased connectivity in early Alzheimer’s is lowered by cancer drug in the lab

Study highlights stroke risk linked to recreational drugs, including among young users

Modeling brain aging and resilience over the lifespan reveals new individual factors

ESC launches guidelines for patients to empower women with cardiovascular disease to make informed pregnancy health decisions 

Towards tailor-made heat expansion-free materials for precision technology

New research delves into the potential for AI to improve radiology workflows and healthcare delivery

Rice selected to lead US Space Force Strategic Technology Institute 4

A new clue to how the body detects physical force

Climate projections warn 20% of Colombia’s cocoa-growing areas could be lost by 2050, but adaptation options remain

New poll: American Heart Association most trusted public health source after personal physician

New ethanol-assisted catalyst design dramatically improves low-temperature nitrogen oxide removal

New review highlights overlooked role of soil erosion in the global nitrogen cycle

Biochar type shapes how water moves through phosphorus rich vegetable soils

Why does the body deem some foods safe and others unsafe?

Report examines cancer care access for Native patients

New book examines how COVID-19 crisis entrenched inequality for women around the world

Evolved robots are born to run and refuse to die

Study finds shared genetic roots of MS across diverse ancestries

Endocrine Society elects Wu as 2027-2028 President

Broad pay ranges in job postings linked to fewer female applicants

How to make magnets act like graphene

[Press-News.org] BMC study: New Hepatitis C treatments cost-effective, but only for selected patients